Featured-Reporter
-
Vanderbilt announces expansion plans for Monroe Carell Jr. Children’s Hospital
Vanderbilt University plans to build a four-floor inpatient expansion on top of the existing structure of the Monroe Carell Jr. Children’s Hospital at Vanderbilt, hospital officials announced Dec. 31, 2013. Each floor of the expansion will add approximately 40,000 square feet to Children’s Hospital that will be used to fulfill… Read MoreJan 2, 2014
-
Ancient chemical bond may aid cancer therapy: study
A chemical bond discovered by Vanderbilt University scientists that is essential for animal life and which hastened the “dawn of the animal kingdom” could lead to new therapies for cancer and other diseases. Read MoreDec 19, 2013
-
Cancer cells combine tools to increase invasiveness
Two features of invasive cancer cells — invadopodia and exosomes — are linked together, Vanderbilt University investigators have discovered. Read MoreDec 19, 2013
-
Biodegradable scaffold may spur wound healing
Biomedical and chemical engineers at Vanderbilt University, working with a pathologist, have constructed a sponge-like, biodegradable tissue “scaffold” that releases an enzyme-blocking molecule to indirectly activate endogenous pathways and enhance tissue regeneration and wound healing. Read MoreDec 19, 2013
-
VUMC positioned to meet challenges ahead: Balser
“The downsizing effort is over.” With those words, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, announced Wednesday that workforce reduction efforts announced in September at Vanderbilt University Medical Center are completed. Read MoreDec 18, 2013
-
Events have long history of making a huge impact
They are touchstones on the Nashville calendar — Iroquois Steeplechase and the Music City Tennis Invitational usher in spring. The Eve of Janus is a celebration of summer. Christmas Village kicks off the holiday season. Read MoreDec 12, 2013
-
Proton transfer powers multidrug resistance: study
Vanderbilt University researchers and their Belgian colleagues have discovered the mechanism behind a multidrug transporter. Their findings, posted this week by Nature Chemical Biology, could lead to new treatments for multidrug resistant bacterial infections. Read MoreDec 12, 2013
-
VU study points to central regulator of neuron development
Developmental biologist Chin Chiang, Ph.D., and his colleagues have discovered that Purkinje neurons in the cerebellum act as central regulators of neuronal development. Read MoreDec 12, 2013
-
GE grant expands global medical outreach efforts
Vanderbilt University has received a $3 million grant from the GE Foundation’s Developing Health Globally program to fund international medical education and research in Kenya and other low-resource regions of the world. Read MoreDec 12, 2013
-
Pioneers of Discovery: Investigator explores how cells decide what’s on surface
Jason MacGurn, Ph.D., a new assistant professor of Cell and Developmental Biology at Vanderbilt, is studying how cells make decisions about the protein composition of the cell surface. Read MoreDec 5, 2013
-
Predictor of prostate cancer outcomes identified
Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread. Read MoreDec 5, 2013
-
Program helps children with complex care needs
David Hall, M.D., has joined the Monroe Carell Jr. Children’s Hospital at Vanderbilt as professor of Clinical Pediatrics and the director of the new Program for Children with Medically Complex Needs within the Division of Hospital Medicine. Read MoreDec 5, 2013
-
First-ever study uses EMRs to spot new disease associations
Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology. Read MoreDec 5, 2013
-
Clinic helps patients cope with Huntington’s disease
Melissa Darnall could easily look around her family reunions and pick out who had Huntington’s disease (HD). The genetic disorder had affected four of her five aunts and uncles and her father, and the balance problems and shakiness typical of HD were readily apparent in those siblings. Read MoreNov 21, 2013
-
Summit explores future of health education system
More than 50 health education professionals and students gathered for a daylong summit at Vanderbilt University Medical Center to explore interprofessional collaboration efforts to meet the growing needs of today’s health care delivery system. Read MoreNov 21, 2013
-
Research contributions of VUMC nurses highlighted
Nursing research and evidence-based practice at Vanderbilt University Medical Center was on full display Nov. 13 at the annual Nursing Research Day. Read MoreNov 21, 2013
-
Children’s Hospital after-hours clinic in Hendersonville debuts
Care is closer at hand for children who need it, when they need it, now that the Monroe Carell Jr. Children’s Hospital at Vanderbilt has opened a second after-hours clinic in Hendersonville, Tenn. Read MoreNov 21, 2013
-
Family’s support enhances cancer research training
John F. Brock III, chairman and CEO of Coca-Cola Enterprises, his wife, Mary, and their three children have established an endowment to support an oncology fellowship at Vanderbilt-Ingram Cancer Center. The Brock Family Fellowship will provide financial assistance long into the future for young physicians, postdoctoral students and medical investigators who are furthering their training in cancer research. Read MoreNov 14, 2013
-
Clinical enterprise braced for shifting health landscape
Vanderbilt University Medical Center staff and faculty are preparing for a new health care landscape, one shaped by a lowered payment regime, greater outside scrutiny of health care quality, new rewards and penalties for hospital and provider safety and quality, and the transfer of financial risk for health outcomes from payers to newly affiliated hospitals and providers. Read MoreNov 14, 2013
-
Immunosuppressive drugs unlikely to raise fetal risk: study
Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism. Read MoreNov 14, 2013